These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9769444)

  • 21. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
    Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the diagnostic performance of FDG-PET and VBM-MRI in very mild Alzheimer's disease.
    Kawachi T; Ishii K; Sakamoto S; Sasaki M; Mori T; Yamashita F; Matsuda H; Mori E
    Eur J Nucl Med Mol Imaging; 2006 Jul; 33(7):801-9. PubMed ID: 16550383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebral muscarinic acetylcholinergic receptor measurement in Alzheimer's disease patients on 11C-N-methyl-4-piperidyl benzilate--comparison with cerebral blood flow and cerebral glucose metabolism.
    Yoshida T; Kuwabara Y; Ichiya Y; Sasaki M; Fukumura T; Ichimiya A; Takita M; Ogomori K; Masuda K
    Ann Nucl Med; 1998 Feb; 12(1):35-42. PubMed ID: 9559960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of gray matter and metabolic reduction in mild Alzheimer's disease using FDG-PET and voxel-based morphometric MR studies.
    Ishii K; Sasaki H; Kono AK; Miyamoto N; Fukuda T; Mori E
    Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):959-63. PubMed ID: 15800784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.
    Drzezga A; Lautenschlager N; Siebner H; Riemenschneider M; Willoch F; Minoshima S; Schwaiger M; Kurz A
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1104-13. PubMed ID: 12764551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of regional metabolic rates of glucose with glasgow coma scale after traumatic brain injury.
    Hattori N; Huang SC; Wu HM; Yeh E; Glenn TC; Vespa PM; McArthur D; Phelps ME; Hovda DA; Bergsneider M
    J Nucl Med; 2003 Nov; 44(11):1709-16. PubMed ID: 14602850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators.
    Alavi A; Newberg AB; Souder E; Berlin JA
    J Nucl Med; 1993 Oct; 34(10):1681-7. PubMed ID: 8410281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissociation of cerebral glucose metabolism and level of consciousness during the period of metabolic depression following human traumatic brain injury.
    Bergsneider M; Hovda DA; Lee SM; Kelly DF; McArthur DL; Vespa PM; Lee JH; Huang SC; Martin NA; Phelps ME; Becker DP
    J Neurotrauma; 2000 May; 17(5):389-401. PubMed ID: 10833058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between both IQ and Mini-Mental State Examination and the regional cerebral glucose metabolism in clinically diagnosed Alzheimer's disease: a PET study.
    Kawano M; Ichimiya A; Ogomori K; Kuwabara Y; Sasaki M; Yoshida T; Tashiro N
    Dement Geriatr Cogn Disord; 2001; 12(2):171-6. PubMed ID: 11173892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of mental deterioration with the Cognitive Abilities Screening Instrument (CASI) and glucose hypometabolism in Alzheimer's disease: the Osaki-Tajiri Project.
    Yamaguchi S; Meguro K; Ishii H; Meguro M; Akanuma K
    J Clin Neurosci; 2009 Nov; 16(11):1430-4. PubMed ID: 19632119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relationship between three neuropsychological tests and cerebral glucose metabolism in Alzheimer's disease].
    Zhang XQ; Min BQ; Ma YC; Yang PJ; Li DP
    Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(2):100-2. PubMed ID: 12812674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease.
    Haxby JV; Duara R; Grady CL; Cutler NR; Rapoport SI
    J Cereb Blood Flow Metab; 1985 Jun; 5(2):193-200. PubMed ID: 3988821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease.
    Mosconi L; Pupi A; De Leon MJ
    Ann N Y Acad Sci; 2008 Dec; 1147():180-95. PubMed ID: 19076441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Reduced metabolism in cerebral cortex correlates with MRI changes and cognitive dysfunction in patients with disseminated sclerosis].
    Blinkenberg M; Rune K; Jensen CV; Ravnborg MH; Kyllingsbaek S; Holm S; Paulson OB; Sørensen PS
    Ugeskr Laeger; 2001 Jul; 163(27):3788-92. PubMed ID: 11466987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease.
    Liguori C; Chiaravalloti A; Sancesario G; Stefani A; Sancesario GM; Mercuri NB; Schillaci O; Pierantozzi M
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2040-9. PubMed ID: 27221635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mapping of hippocampal pH and neurochemicals from in vivo multi-voxel 31P study in healthy normal young male/female, mild cognitive impairment, and Alzheimer's disease.
    Mandal PK; Akolkar H; Tripathi M
    J Alzheimers Dis; 2012; 31 Suppl 3():S75-86. PubMed ID: 22426021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The comparison of the regional cerebral metabolism rate of glucose in Alzheimer's disease with mild cognitive impairment].
    Cao Q; Jiang K; Liu Y; Zhang M; Xiao S; Zuo C; Huang H
    Zhonghua Yi Xue Za Zhi; 2002 Dec; 82(23):1613-6. PubMed ID: 12667368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease.
    Nobili F; Brugnolo A; Calvini P; Copello F; De Leo C; Girtler N; Morbelli S; Piccardo A; Vitali P; Rodriguez G
    Clin Neurophysiol; 2005 Feb; 116(2):364-75. PubMed ID: 15661114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Engler H; Forsberg A; Almkvist O; Blomquist G; Larsson E; Savitcheva I; Wall A; Ringheim A; Långström B; Nordberg A
    Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients.
    Kim EJ; Cho SS; Jeong Y; Park KC; Kang SJ; Kang E; Kim SE; Lee KH; Na DL
    Brain; 2005 Aug; 128(Pt 8):1790-801. PubMed ID: 15888536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.